跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
DARUNAVIR VIVANTA 400 MG COMPRIMIDOS RECUBIERTOS CON PELICULAS EFG - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
DARUNAVIR VIVANTA 400 MG COMPRIMIDOS RECUBIERTOS CON PELICULAS EFG
Approved
STANDARD
DARUNAVIR VIVANTA 400 MG COMPRIMIDOS RECUBIERTOS CON PELICULAS EFG
Vivanta Generics S.R.O.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Dec 28, 2021
Approval ID
165a6d9391d4bcfe
Company
Vivanta Generics S.R.O.
Type
Standard
Approval Details
Approval Id
165a6d9391d4bcfe
Drug Cima Aemps Name
DARUNAVIR VIVANTA 400 MG COMPRIMIDOS RECUBIERTOS CON PELICULAS EFG
Register Number
86482
Holder Company Name
Vivanta Generics S.R.O.
Marketing Company Name
Vivanta Generics S.R.O. Sucursal En Espana
Authorization Date
2021-12-28
Dosage Form
COMPRIMIDO RECUBIERTO CON PELÍCULA
Dose
400 mg
Route Of Administration
VÍA ORAL
Prescription Type
Diagnóstico Hospitalario
Commercialized
No
Company Name
Vivanta Generics S.R.O.
Active Ingredients
DARUNAVIR
400 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Dec 28, 2021
Approval ID
165a6d9391d4bcfe
Type
Standard
Back to CIMA-AEMPS Approvals